On Tuesday, Caribou Biosciences Inc (NASDAQ: CRBU) was -3.49% drop from the session before settling in for the closing price of $1.72. A 52-week range for CRBU has been $0.66 – $3.54.
A company in the Healthcare sector has dropped its sales by -33.41% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 3.38%. With a float of $82.78 million, this company’s outstanding shares have now reached $93.47 million.
In an organization with 147 employees, it is important to assess its efficiency.
Caribou Biosciences Inc (CRBU) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Caribou Biosciences Inc stocks. The insider ownership of Caribou Biosciences Inc is 11.44%, while institutional ownership is 37.02%. The most recent insider transaction that took place on Mar 14 ’25, was worth 20,400. In this transaction President and CEO of this company bought 20,000 shares at a rate of $1.02, taking the stock ownership to the 3,369,395 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Chief Legal Officer sold 3,564 for $1.35, making the entire transaction worth $4,811. This insider now owns 443,502 shares in total.
Caribou Biosciences Inc (CRBU) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.39 earnings per share (EPS) during the time that was better than consensus figure (set at -0.4) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.17% during the next five years compared to -33.41% drop over the previous five years of trading.
Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators
You can see what Caribou Biosciences Inc (CRBU) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.70, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.43 in one year’s time.
Technical Analysis of Caribou Biosciences Inc (CRBU)
Let’s dig in a bit further. During the last 5-days, its volume was 1.1 million. That was inferior than the volume of 1.55 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 23.15%.
During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 2.08%, which indicates a significant decrease from 11.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0957 in the past 14 days, which was lower than the 0.1701 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0849, while its 200-day Moving Average is $1.6132. However, in the short run, Caribou Biosciences Inc’s stock first resistance to watch stands at $1.7100. Second resistance stands at $1.7600. The third major resistance level sits at $1.8000. If the price goes on to break the first support level at $1.6200, it is likely to go to the next support level at $1.5800. Assuming the price breaks the second support level, the third support level stands at $1.5300.
Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats
There are 93,468K outstanding shares of the company, which has a market capitalization of 155.16 million. As of now, sales total 9,990 K while income totals -149,110 K. Its latest quarter income was 2,200 K while its last quarter net income were -27,550 K.
